Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Titan Pharma (TTNP)

Titan Pharma (TTNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,090
  • Shares Outstanding, K 914
  • Annual Sales, $ 180 K
  • Annual Income, $ -5,570 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.12
  • Price/Sales 16.05
  • Price/Cash Flow N/A
  • Price/Book 0.74

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.15 +7.13%
on 12/20/24
4.50 -24.89%
on 11/27/24
-0.27 (-7.40%)
since 11/20/24
3-Month
3.15 +7.13%
on 12/20/24
5.68 -40.52%
on 09/23/24
-2.28 (-40.28%)
since 09/20/24
52-Week
3.15 +7.13%
on 12/20/24
14.80 -77.16%
on 08/20/24
-1.82 (-35.02%)
since 12/20/23

Most Recent Stories

More News
Titan Pharmaceuticals Faces Nasdaq Compliance Challenges with Reporting and Audit Committee Requirements

Titan Pharmaceuticals faces non-compliance notices from Nasdaq for delayed filings and audit committee requirements, planning corrective actions.Quiver AI SummaryTitan Pharmaceuticals, Inc. received a...

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

TTNP : 3.38 (+4.64%)
Stock Index Futures Tread Water as Investors Brace for Fed Minutes and Powell’s Speech

September S&P 500 E-Mini futures (ESU24) are up +0.01%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as market participants geared up for the release of the minutes of the...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
ZIM : 18.29 (-0.49%)
AMD : 119.21 (+0.28%)
MCD : 292.68 (+0.84%)
HPQ : 32.94 (+1.48%)
LOW : 247.72 (+1.31%)
MDT : 81.03 (+1.30%)
KEYS : 163.22 (+2.11%)
TOL : 125.45 (+1.33%)
AS : 28.18 (+2.47%)
TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q1 Earnings Snapshot

Titan Pharmaceuticals: Q1 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q3 Earnings Snapshot

Titan Pharmaceuticals: Q3 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals Announces Board Expansion and Management Changes

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board")...

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has...

TTNP : 3.38 (+4.64%)
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist...

TTNP : 3.38 (+4.64%)

Business Summary

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical...

See More

Key Turning Points

3rd Resistance Point 3.85
2nd Resistance Point 3.67
1st Resistance Point 3.52
Last Price 3.38
1st Support Level 3.20
2nd Support Level 3.01
3rd Support Level 2.87

See More

52-Week High 14.80
Fibonacci 61.8% 10.35
Fibonacci 50% 8.98
Fibonacci 38.2% 7.60
Last Price 3.38
52-Week Low 3.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar